The Japanese encephalitis vaccine market size is projected to accelerate at a CAGR of 5.98% and reach an estimated value of USD 58.27 million by 2026.

This Japanese encephalitis vaccines market research report extensively covers market segmentation by type (inactivated vaccines, recombinant vaccines, and live attenuated vaccines) and geography (Asia, ROW, Europe, and North America).

The Japanese encephalitis vaccines market report also offers information on several market vendors, including Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., KM Biologics Co. Ltd., Medigen Inc., Panacea Biotec Ltd, Sanofi, Shandong Hengye Biotechnology Co. Ltd., VA Bio+Tech Park, and Valneva SE among others. One of the key highlights of this report is the valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.

What will the Japanese Encephalitis Vaccines Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Japanese Encephalitis Vaccines Market Size for the Forecast Period and Other Important Statistics

Japanese Encephalitis Vaccines Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The inclusion of a national immunization plan is notably driving the Japanese encephalitis vaccines market growth, although factors such as demand-supply imbalance may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the Japanese encephalitis vaccine industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Japanese Encephalitis Vaccines Market Driver

• One of the key factors driving the Japanese encephalitis vaccine market growth is its inclusion in the national immunization plan.
• The increasing number of indications caused by deadly viruses has encouraged the governments to come up with national immunization plans. For instance,
  • In 1978, the Ministry of Health and Family Welfare, Government of India, introduced the Expanded Programme of Immunization, which was changed to the Universal Immunization Programme in 1985.
  • The aim of this program was to ensure that the population in the affected parts of the country were immunized against infectious diseases.
• The global demand for the Japanese encephalitis vaccine is estimated to be in the range of 75-100 million doses per year, with a majority of the demand coming from China, India, Japan, and South Korea.
• Asian countries such as Thailand, Malaysia, and the Philippines are also contributing to the increasing demand for Japanese encephalitis vaccines which, in turn, would fuel the market growth in the forecast years.

Key Japanese Encephalitis Vaccines Market Trend

•  Novel vaccine technology is one of the key Japanese encephalitis vaccine market trends that is expected to impact the industry positively in the forecast period. 
• There are different types of vaccines are available for the prevention of the indication, however, the market still witnesses an unmet need for highly effective vaccines for the prevention of the indication.
• Researchers are conducting studies on micro ribonucleic acid (microRNA) as a potential therapeutic candidate for Japanese encephalitis.
• Various studies are being conducted to understand the ability of microRNAs within the viral genome of an attenuated virus. For instance;
  • The studies show that microRNA-155 can regulate the inflammatory response caused by the Japanese encephalitis virus.
• Investment in R&D is expected to further support the market growth in the coming years.

Key Japanese Encephalitis Vaccines Market Challenge

• Demand-supply imbalance is one of the key challenges hindering the Japanese encephalitis vaccine market growth.
• As most cases of Japanese encephalitis are seasonal, various manufacturers tend to manufacture the vaccines in large quantities and store them.
• Japanese encephalitis vaccine, despite being produced in large quantities, faces the risk of low shelf life, as most of these vaccines (on average) have a shelf life of fewer than two years.
• The market faces issues with storage, as these vaccines are required to be stored in cold chain storage.
• The cost of storing vaccines is very high, which leaves various small and mid-sized vendors with manufacturing the vaccines only when the demand is high in the market.
• Japanese encephalitis vaccines also take a long time to manufacture and deliver to the required region, which is creating a gap between the demand and the supply in the market.
• Such factors may limit the market growth in the coming years.

This Japanese encephalitis vaccines market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Which are the Key Regions for Japanese Encephalitis Vaccines Market?

For more insights on the market share of various regions Request for a FREE sample now!

72% of the market's growth will originate from Asia during the forecast period. China, India, Japan, and South Korea (Republic of Korea) are the key markets for Japanese encephalitis vaccines in Asia. Market growth in this region will be faster than the growth of the market in North America and ROW.

The increase in the risk of the indication, as Asian countries, including India and China are currently at the highest risk of coming into contact with the Japanese encephalitis virus, will facilitate the Japanese encephalitis vaccines market growth in APAC over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

Due to the outbreak of the COVID-19 pandemic, the Japanese encephalitis vaccine market in APAC witnessed a negative impact on its growth both in 2020 and 2021. As Japan and India are the major manufacturers of these vaccines, the outbreak of the pandemic adversely impacted several countries that rely on the import of the vaccines from these countries. However, the ongoing vaccination drives for COVID-19 are anticipated to bring about a pragmatic change in the operations and R&D activities of pharmaceutical companies. As a result, the regional Japanese encephalitis vaccine market will witness moderate growth during the forecast period.

What are the Revenue-generating Type Segments in the Japanese Encephalitis Vaccines Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The Japanese encephalitis vaccine market share growth by the inactivated vaccines will be significant during the forecast period. The need for booster injections for inactivated vaccines is expected to help the segment grow in terms of both volume and value in the coming years.

This report provides an accurate prediction of the contribution of all the segments to the growth of the Japanese encephalitis vaccines market size and actionable market insights on post COVID-19 impact on each segment.

Who are the Major Japanese Encephalitis Vaccines Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Adimmune Corp.
• Bharat Biotech Ltd.
• Biological E. Ltd.
• KM Biologics Co. Ltd.
• Medigen Inc. 
• Panacea Biotec Ltd
• Sanofi
• Shandong Hengye Biotechnology Co. Ltd.
• VA Bio+Tech Park
• Valneva SE

This statistical study of the Japanese encephalitis vaccine market encompasses successful business strategies deployed by the key vendors. The Japanese encephalitis vaccines market is concentrated and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

• Adimmune Corp. - The company offers infant nutrients such as Similac Probiotic Tri-Blend, Similac organic with A2 milk, Pure Bliss for essential protein, minerals, and other nutrients to support an infant's growth.
• Adimmune Corp. - Under the established pharmaceuticals products segment, the company manufacturers branded generic pharmaceuticals for established and emerging markets.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The Japanese encephalitis vaccines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Parent Market Analysis

Technavio categorizes the global Japanese encephalitis vaccines market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the Japanese encephalitis vaccines market during the forecast period.

Japanese Encephalitis Vaccines Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the Japanese encephalitis vaccines market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Request for a FREE sample

What are the Key Data Covered in this Japanese Encephalitis Vaccines Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive Japanese encephalitis vaccines market growth during the next five years
• Precise estimation of the Japanese encephalitis vaccines market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the Japanese encephalitis vaccines industry across Asia, ROW, Europe, and North America
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of Japanese encephalitis vaccines market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch